13F-HR filed by SECTOR GAMMA AS
SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-12, with 40 holding rows worth $460,970,513.
- Accession
- 0000945621-26-001027
- Filer
- CIK 1475373
- Filed
- 2026-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 40 entries on the cover page, a total value of $460,970,513 stated on the cover page (in dollars after the unit check, H1), rows summing to $460,970,513 with VALUE read as dollars as filed, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Company | 110122108 | COM | 726,115 | $41,838,746 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 217,008 | $27,885,528 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 352,437 | $27,571,147 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 1,004,215 | $24,181,497 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 170,753 | $19,356,560 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 44,499 | $17,209,098 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 294,918 | $16,875,208 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 33,584 | $16,837,674 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 155,337 | $16,069,613 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 77,944 | $15,060,340 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 189,468 | $15,022,918 | dollars as filed | |
| BECTON DICKINSON & CO | 075887109 | COM | 93,168 | $14,099,113 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 147,444 | $13,379,069 | dollars as filed | |
| GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK | 36266G107 | Stock | 207,863 | $13,305,311 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 142,307 | $12,251,210 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 54,163 | $11,702,458 | dollars as filed | |
| QIAGEN NV ORD SHARES | N72482156 | Stock | 287,640 | $11,246,724 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 162,405 | $10,424,777 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 15,780 | $9,839,461 | dollars as filed | |
| BIO RAD LABS INC | 090572207 | CL A | 33,350 | $9,791,894 | dollars as filed | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 40,689 | $9,666,079 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 26,281 | $9,516,876 | dollars as filed | |
| BRUKER CORP | 116794108 | COM | 152,352 | $9,168,543 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 906,088 | $8,970,271 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 100,000 | $8,157,000 | dollars as filed | |
| LABCORP HOLDINGS INC COM SHS | 504922105 | Stock | 26,019 | $7,285,320 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 102,122 | $6,877,917 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 21,305 | $5,682,470 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 60,402 | $5,463,965 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 241,739 | $5,284,415 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 121,128 | $5,169,743 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 433,012 | $4,750,142 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 80,000 | $4,544,800 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 114,628 | $4,289,380 | dollars as filed | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 267,091 | $4,030,403 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 968,466 | $4,028,819 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 45,000 | $3,833,550 | dollars as filed | |
| ORGANON & CO COMMON STOCK | 68622V106 | Stock | 270,781 | $3,666,375 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 686,844 | $3,502,904 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 185,177 | $3,133,195 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000945621-26-001027 | this filing | 2026-08-12 | acceptance time not in the bulk data set |